KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,767 | +70.4% | 2,468 | +59.2% | 0.00% | 0.0% |
| Q2 2023 | $13,950 | +14.5% | 1,550 | 0.0% | 0.00% | – |
| Q1 2023 | $12,183 | -1.1% | 1,550 | 0.0% | 0.00% | – |
| Q4 2022 | $12,323 | -44.0% | 1,550 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $22,000 | +46.7% | 1,550 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $15,000 | -34.8% | 1,550 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $23,000 | +9.5% | 1,550 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $21,000 | -22.2% | 1,550 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | -27.0% | 1,550 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $37,000 | -7.5% | 1,550 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $40,000 | +100.0% | 1,550 | +50.5% | 0.00% | +100.0% |
| Q4 2020 | $20,000 | +53.8% | 1,030 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | +8.3% | 1,030 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $12,000 | +50.0% | 1,030 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -55.6% | 1,030 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $18,000 | +50.0% | 1,030 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $12,000 | -47.8% | 1,030 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $23,000 | – | 1,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |